These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. McKinney M, Stenstrom S, Richelson E. Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089 [Abstract] [Full Text] [Related]
4. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells. Lai WS, el-Fakahany EE. J Pharmacol Exp Ther; 1987 May; 241(2):366-73. PubMed ID: 3033212 [Abstract] [Full Text] [Related]
9. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation. McKinney M, Richelson E. Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477 [Abstract] [Full Text] [Related]
10. Lithium ions inhibit function of low- but not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115). Kanba S, Pfenning M, Richelson E. Psychopharmacology (Berl); 1985 Sep; 86(4):413-6. PubMed ID: 2994150 [Abstract] [Full Text] [Related]
11. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites. Cioffi CL, el-Fakahany EE. J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226 [Abstract] [Full Text] [Related]
13. Cellular mechanism involved in the synthesis of cyclic GMP in nervous tissues. Deguchi T, Ohsako S, Nakane M, Ichikawa M, Yoshioka M. J Neural Transm Suppl; 1983 Sep; 18():369-78. PubMed ID: 6135749 [Abstract] [Full Text] [Related]
14. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A. Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619 [Abstract] [Full Text] [Related]
15. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation. Murad F, Waldman S, Molina C, Bennett B, Leitman D. Prog Clin Biol Res; 1987 Jan; 249():65-76. PubMed ID: 2890172 [Abstract] [Full Text] [Related]
16. Blockade of N1E-115 murine neuroblastoma muscarinic receptor function by agents that affect the metabolism of arachidonic acid. McKinney M, Richelson E. Biochem Pharmacol; 1986 Jul 15; 35(14):2389-97. PubMed ID: 3015148 [Abstract] [Full Text] [Related]
17. Effects of pertussis toxin on cAMP and cGMP responses to carbamylcholine in N1E-115 neuroblastoma cells. Bruni P, Burns DL, Hewlett EL, Moss J. Mol Pharmacol; 1985 Aug 15; 28(2):229-34. PubMed ID: 2991740 [Abstract] [Full Text] [Related]
18. Ethanol-induced inhibition of guanylate cyclase in liver, pancreas, stomach and intestine. Vesely DL, Levey GS. Res Commun Chem Pathol Pharmacol; 1977 Jun 15; 17(2):215-24. PubMed ID: 17894 [Abstract] [Full Text] [Related]
19. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R. Br J Pharmacol; 1997 Feb 15; 120(4):681-9. PubMed ID: 9051308 [Abstract] [Full Text] [Related]
20. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation. Leitman DC, Murad F. Endocrinol Metab Clin North Am; 1987 Mar 15; 16(1):79-105. PubMed ID: 2892671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]